mAbs (B&H Biotechnologies)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NamemAbs (B&H Biotechnologies)
Drug Alias Nameanticancer mAbs (B&H Biotechnologies)
ClassificationDiagnostic agent (In vivo)Biologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsInflammationNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesB&H Biotechnologies LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesB&H Biotechnologies LLC
Active IndicationsN/A
Inactive IndicationsInflammationNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A